ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,507,857 | +66.2% | 12,670 | +148.9% | 0.18% | +11.1% |
| Q2 2023 | $906,987 | -34.5% | 5,090 | -39.4% | 0.16% | -37.2% |
| Q1 2023 | $1,385,664 | +101.5% | 8,400 | +92.4% | 0.26% | +57.3% |
| Q4 2022 | $687,558 | +40.0% | 4,366 | +46.2% | 0.16% | +24.2% |
| Q2 2022 | $491,000 | -1.8% | 2,987 | +32.9% | 0.13% | -2.2% |
| Q1 2022 | $500,000 | -51.9% | 2,248 | -49.5% | 0.14% | -60.2% |
| Q3 2021 | $1,039,000 | +118.7% | 4,450 | +71.2% | 0.34% | -4.2% |
| Q3 2020 | $475,000 | +21.5% | 2,600 | +22.4% | 0.35% | -28.5% |
| Q2 2020 | $391,000 | -64.7% | 2,124 | -54.1% | 0.50% | -9.0% |
| Q1 2019 | $1,107,000 | +164.2% | 4,626 | +211.9% | 0.54% | +90.9% |
| Q3 2018 | $419,000 | +82.2% | 1,483 | +89.4% | 0.28% | +61.0% |
| Q2 2018 | $230,000 | +8.0% | 783 | -59.8% | 0.18% | +24.6% |
| Q3 2015 | $213,000 | -85.7% | 1,948 | -91.1% | 0.14% | -51.4% |
| Q3 2013 | $1,491,000 | – | 21,943 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |